Immunohistochemistry for intestinal type adenocarcinoma is known to reveal positivity for pancytokeratin, EMA, B72.3, BerEP4, Leu M1, CK20, CDX2 and variable CK7 immunoreactivity. This evidence concerns the gene CDX2 and intestinal type adenocarcinoma.